Tocqueville Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-21,415
| Closed | -$385K | – | 686 |
|
|
2020
Q2 | $385K | Hold |
21,415
| – | – | 0.01% | 531 |
|
|
2020
Q1 | $153K | Sell |
21,415
-376,488
| -95% | -$2.69M | ﹤0.01% | 606 |
|
|
2019
Q4 | $9.5M | Sell |
397,903
-185
| -0% | -$4.42K | 0.14% | 165 |
|
|
2019
Q3 | $10.7M | Sell |
398,088
-70,026
| -15% | -$1.88M | 0.14% | 170 |
|
|
2019
Q2 | $12.7M | Sell |
468,114
-8,631
| -2% | -$234K | 0.16% | 160 |
|
|
2019
Q1 | $16.5M | Sell |
476,745
-128,840
| -21% | -$4.47M | 0.22% | 128 |
|
|
2018
Q4 | $11.8M | Buy |
605,585
+168,905
| +39% | +$3.3M | 0.18% | 148 |
|
|
2018
Q3 | $11.6M | Buy |
436,680
+104,590
| +31% | +$2.79M | 0.15% | 178 |
|
|
2018
Q2 | $12.5M | Buy |
+332,090
| New | +$12.5M | 0.16% | 162 |
|
|
2016
Q2 | – | Sell |
-10,650
| Closed | -$217K | – | 893 |
|
|
2016
Q1 | $217K | Sell |
10,650
-34,200
| -76% | -$697K | ﹤0.01% | 793 |
|
|
2015
Q4 | $2.31M | Buy |
44,850
+4,900
| +12% | +$252K | 0.03% | 397 |
|
|
2015
Q3 | $1.7M | Buy |
39,950
+24,950
| +166% | +$1.06M | 0.02% | 469 |
|
|
2015
Q2 | $683K | Buy |
15,000
+3,500
| +30% | +$159K | 0.01% | 643 |
|
|
2015
Q1 | $437K | Buy |
+11,500
| New | +$437K | 0.01% | 746 |
|